Moors & Cabot’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,700
Closed -$254K 893
2024
Q1
$254K Buy
10,700
+1,400
+15% +$31.1K 0.01% 727
2023
Q4
$223K Sell
9,300
-1,650
-15% -$35.9K 0.01% 717
2023
Q3
$239K Sell
10,950
-150
-1% -$3.14K 0.02% 674
2023
Q2
$212K Buy
+11,100
New +$214K 0.01% 727

Other funds holding EXEL

Moors & Cabot's EXEL Position: Q2 2024 in Review

Moors & Cabot sold out of Exelixis (EXEL) in Q2 2024, closing a stake of 10,700 shares — an estimated $254K sold.

Moors & Cabot first reported a position in EXEL in Q2 2023 and held it in 4 quarters. The position peaked at $254K in Q1 2024. 413 funds tracked by Wall St. Rank hold EXEL as of Q2 2024.

  • Moors & Cabot reported no remaining Exelixis position as of Q2 2024 after selling out during the quarter.
  • Moors & Cabot sold 10,700 Exelixis shares in Q2 2024, an estimated $254K.
  • Moors & Cabot first reported a position in Exelixis in Q2 2023 and held it in 4 quarters.
  • Moors & Cabot's Exelixis position peaked at $254K in Q1 2024.
  • 413 funds tracked by Wall St. Rank held Exelixis as of Q2 2024.

Based on Moors & Cabot's 13F filing for Q2 2024, filed 9 Aug 2024.